| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 650263 | Null | 0.0459335986102862 | 0.32747248 |
| NSC 656599 | Null | 0.0459335986102862 | -0.49689805 |
| NSC 658142 | 2-(1-(4-(2-Pyridyl)piperazino))naphthazarin | 0.0459335986102862 | -0.42179221 |
| NSC 668260 | 2-(5-Bromouracil-1-yl)-4-methylene-5-oxo-2-(p-phenylphenyl)-2,3,4,5-tetrhydrofuran | 0.0459335986102862 | -0.37897405 |
| NSC 673415 | Null | 0.0459335986102862 | -0.35621601 |
| NSC 674913 | Null | 0.0459335986102862 | -0.42191537 |
| NSC 681462 | 6,8-Methanoisoquinoline, 5,5'-(1,3-phenylenedimethyene) bis[3-(2-pyridinyl)-7,7-dimethyl-5,6,7,8-tetrahydro- | 0.0459335986102862 | -0.37026439 |
| NSC 682571 | Null | 0.0459335986102862 | 0.38498436 |
| NSC 684836 | Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- | 0.0459335986102862 | -0.44040183 |
| NSC 687330 | Adenosine, 2'-amino-2'-deoxy-3',5'- O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]- (9CI) | 0.0459335986102862 | -0.3870011 |